In many countries, HPV testing has replaced cervical cytology as the primary screening method for cervical cancer.
While HPV testing has high sensitivity, its limited specificity necessitates triage to reduce unnecessary colposcopy referrals.
This study evaluates the performance of cervical cytology (TCT) and the GynTectÂ® six-gene methylation test as triage methods for HPV-positive women.
